Puma Biotechnology
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Puma Biotechnology's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3% to $235,637,000. The net income raised on $21,591,000 and profit margin reached 9%. Total operating expenses were $140,315,000.

Profit Margin

Puma Biotechnology, Inc. (NASDAQ:PBYI): Profit margin
2014 0 -142M
2015 0 -239.3M
2016 0 -276M
2017 27.7M -292M -1054.15%
2018 251M -113.6M -45.26%
2019 272.3M -82.72M -30.38%
2020 225.1M -60M -26.65%
2021 253.2M -29.1M -11.49%
2022 228M 912K 0.4%
2023 235.63M 21.59M 9.16%

PBYI Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
235.63M228M253.2M225.1M272.3M251M27.7M000
Cost of revenue
62.68M55.1M63.7M39.4M36.8M34.6M5.6M0776K0
Gross profit
172.95M172.9M189.5M185.7M235.5M216.4M22.1M0-776K0
Operating exp.
Research and development
50.38M52.2M71.9M97.7M132.9M164.9M207.8M222.8M208.5M122.9M
Selling and marketing
881K22K6K-88K1.19M12K0000
Total operating expenses
140.31M142.2M188.2M216.1M274.6M311.1M314.5M276.6M240.3M142.3M
Operating income
32.64M23.7M-8.89M-30.4M-39.1M-94.7M-292.4M-276.6M-240.3M-142.3M
Other income (expenses), net
-9.96M-23.2M-19.90M-29.38M-36.5M-9.7M435K-400K996K310K
Income before tax
22.67M500K-28.8M-59.8M-75.6M-113.6M-292M-276M-239.3M-142M
Income tax expense
1.08M500K300K200K7.12M-7.91M-2.21M-2.14M-1.75M-941K
Net income
21.59M912K-29.1M-60M-82.72M-113.6M-292M-276M-239.3M-142M
Earnings per share
Basic EPS
0.460.02-0.72-1.52-2.13-2.99-7.86-8.29-7.45-4.73
Diluted EPS
0.450.02-0.72-1.52-2.13-2.99-7.86-8.29-7.45-4.73
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source